[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352231-105":59,"doc-detail-352231-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","nonspecific-mediastinal-lymphadenopathy-is-associated-with-metachronous-multiple-cancers-following-endoscopic-submucosal-dissection-of-esophageal-squamous-cell-carcinoma","Nonspecific mediastinal lymphadenopathy is associated with metachronous multiple cancers following endoscopic submucosal dissection of esophageal squamous cell carcinoma","","Background: Endoscopic submucosal dissection (ESD) is standard for superficial esophageal squamous cell carcinoma, but esophageal preservation increases the risk of metachronous multiple cancers. Nonspecific mediastinal lymphadenopathy (NML) is commonly observed, while its clinical significance after ESD remains unclear. Methods: A retrospective cohort of 154 curatively treated ESCC patients (2015–2024) assessed Lugol-voiding lesion grade and NML on pretreatment computed tomography, with recurrence risk analyzed using Kaplan–Meier and Cox models. Results: NML appeared in 59.6% and was linked to lymphovascular invasion, and independently predicted recurrence, including in Lugol B/C cases. Conclusions: NML evaluation combined with Lugol-voiding lesion grade may improve risk stratification and surveillance planning.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nonspecific-mediastinal-lymphadenopathy-is-associated-with-metachronous-multiple-cancers-following-endoscopic-submucosal-dissection-of-esophageal-squamous-cell-carcinoma/352231/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nonspecific-mediastinal-lymphadenopathy-is-associated-with-metachronous-multiple-cancers-following-endoscopic-submucosal-dissection-of-esophageal-squamous-cell-carcinoma/352231.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What clinical question does the study address about nonspecific mediastinal lymphadenopathy (NML)?","Question",{"text":113,"@type":114},"It evaluates whether NML has clinical significance for patients with esophageal squamous cell carcinoma who undergo curative endoscopic submucosal dissection (ESD), specifically regarding the risk of developing metachronous multiple cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was NML assessed and how were recurrence associations analyzed?",{"text":118,"@type":114},"Pretreatment computed tomography was used to evaluate Lugol-voiding lesion grade and NML. Associations with pathological findings and metachronous recurrence were analyzed using Kaplan–Meier and Cox regression analyses.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the key results regarding NML and metachronous cancer recurrence?",{"text":122,"@type":114},"NML was identified in 68 patients (59.6%), was significantly associated with lymphovascular invasion, and independently predicted recurrence. In Lugol-voiding lesion grade B/C cases, NML also predicted recurrence-free survival.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352231,1790148782,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Clinical and Experimental Medicine (2026) 26:67  \n[https://doi.org/10.1007/s10238-025-02012-3](https://doi.org/10.1007/s10238-025-02012-3)  \nRESEARCH  \nNonspecific mediastinal lymphadenopathy is associated with metachronous multiple cancers following endoscopic submucosal dissection of esophageal squamous cell carcinoma  \nNatsuki Ishida1 · Keisuke Inagaki1 · Tomoyuki Niwa1 · Tomohiro Takebe1 · Kenichi Takahashi1 · Yusuke Asai1 · Kiichi Sugiura1 · Tomoharu Matsuura2 · MihokoYamade1 · Moriya Iwaizumi2 · Yasushi Hamaya1 · Takanori Yamada3 · Ken Sugimoto1 · Satoshi Osawa3  \nReceived: 15 November 2025 / Accepted: 15 December 2025 © The Author(s) 2025  \nAbstract  \nBackground Endoscopic submucosal dissection is the standard treatment for superficial esophageal squamous cell carcinoma. However, esophageal preservation following this procedure increases the risk of metachronous multiple cancers. Lugol-voiding lesion grade and alcohol-related genetic polymorphisms have been identified as risk factors, but the role of nonspecific mediastinal lymphadenopathy remains unclear.  \nMethods We retrospectively analyzed the data of 154 patients who underwent curative endoscopic submucosal dissection for esophageal squamous cell carcinoma at Hamamatsu University Hospital between 2015 and 2024. Pretreatment computed tomography was used to evaluate the Lugol-voiding lesion grade and nonspecific mediastinal lymphadenopathy. Associations with pathological findings and the development of metachronous multiple esophageal squamous cell carcinoma were assessed using Kaplan–Meier and Cox regression analyses.  \nResults Nonspecific mediastinal lymphadenopathy was identified in 68 patients (59.6%) . Pathological analysis including 154 patients revealed that nonspecific mediastinal lymphadenopathy was significantly associated with lymphovascular invasion (P= 0.026) but not with invasion depth or curative resection. During follow-up and metachronous analysis including 114 patients, 21 patients developed metachronous multiple esophageal squamous cell carcinoma. Both Lugol-voiding lesion grade and nonspecific mediastinal lymphadenopathy were independent predictors of recurrence. Subgroup analysis restricted to Lugol-voiding lesion grade B/C cases confirmed that nonspecific mediastinal lymphadenopathy remained predictive of recurrence-free survival (P= 0.007) .  \nConclusions Nonspecific mediastinal lymphadenopathy independently predicts the development of metachronous esophageal squamous cell carcinoma after endoscopic submucosal dissection. Evaluation of nonspecific mediastinal lymphadenopathy in combination with Lugol-voiding lesion grade may improve risk stratification and optimize surveillance strategies.  \nKeywords Esophageal squamous cell carcinoma · Endoscopic submucosal dissection · Mediastinal lymphadenopathy · Lugol-voiding lesion · Metachronous cancer  \n􀀍 Natsuki Ishida [ma03006@hama-med.ac.jp](ma03006@hama-med.ac.jp)  \n1 First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan  \n2 Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan  \n3 Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan  \nIntroduction  \nEsophageal squamous cell carcinoma (ESCC) accounts formost esophageal cancers [1] . Although surgical resection was once the only treatment available, endoscopic submucosal dissection (ESD) has become the standard treatment for early-stage disease [2–4] . Unlike surgical treatment, which removes a large portion of the esophagus, ESD preserves the organ, raising the risk of developing multiple metachronous cancers [5, 6] . Therefore, regular endoscopic  \n1 3  \nfollow-up is recommended after radical resection of ESCC through ESD to enable early detection and treatment of metachronous multiple cancers while endoscopic resection is still possible.  \nSmoking and alcohol consumption are established risk f","cbCaiiG393XUDY4t","https://ap.wps.com/l/cbCaiiG393XUDY4t","pdf",1371521,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"What clinical question does the study address about nonspecific mediastinal lymphadenopathy (NML)?\",\"answer\":\"It evaluates whether NML has clinical significance for patients with esophageal squamous cell carcinoma who undergo curative endoscopic submucosal dissection (ESD), specifically regarding the risk of developing metachronous multiple cancers.\"},{\"question\":\"How was NML assessed and how were recurrence associations analyzed?\",\"answer\":\"Pretreatment computed tomography was used to evaluate Lugol-voiding lesion grade and NML. Associations with pathological findings and metachronous recurrence were analyzed using Kaplan–Meier and Cox regression analyses.\"},{\"question\":\"What were the key results regarding NML and metachronous cancer recurrence?\",\"answer\":\"NML was identified in 68 patients (59.6%), was significantly associated with lymphovascular invasion, and independently predicted recurrence. In Lugol-voiding lesion grade B/C cases, NML also predicted recurrence-free survival.\"}]","Nonspecific mediastinal lymphadenopathy is associated with metachronous multiple cancers following endoscopic submucosal dissection of esophageal squamous cell carcinoma | PDF",1790098443,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0979a3491bee015e7a37e3945af8f392.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49744f6df6e2128d0d932934d0267f66.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61e41bbb1d002f56a6b69d146c4fbeb2.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e579b55da66252ebabc6a9b867cb583.webp",980,1301]